Abstract: The invention relates to the use of one or more cannabinoids, particularly THC and/or CBD in combination with a non-cannabinoid chemotherapeutic agent in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumour, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM). The non-cannabinoid chemotherapeutic agent may be a selective estrogen receptor modulator or an alkylating agent.

Abstract: The present invention relates to ligands of the peripheral cannabinoid receptor CB2, especially (+)-?-pinene derivatives, and to pharmaceutical compositions thereof, which are useful for promoting, inducing and enhancing neurogenesis including neural cell regeneration. In particular, pharmaceutical compositions of the invention will be useful for preventing, alleviating or treating neurological injuries or damages to the CNS or the PNS associated with physical injury, ischemia, neurodegenerative disorders, certain medical procedures or medications, tumors, infections, metabolic or nutritional disorders, cognition or mood disorders, and various medical conditions associated with neural damage or destruction.

Abstract: The present invention relates generally to applicators and a method of coloring antiseptics. More specifically, in one embodiment, the present invention relates to an applicator having a flexible hollow body containing antiseptic to be applied. The applicator also has a porous element containing colorant positioned such that the antiseptic flows through the porous element containing colorant. Colorant is transferred to the antiseptic as it flows through the porous element. The resulting colored solution may be applied to the desired surface.

Abstract: Applicators and a method of coloring antiseptics are provided. More specifically, in one embodiment, an applicator having a flexible hollow body containing antiseptic to be applied is provided. The applicator also has a porous element containing colorant positioned such that the antiseptic flows through the porous element containing colorant. Colorant is transferred to the antiseptic as it flows through the porous element. The resulting colored solution may be applied to the desired surface.

Abstract: The present invention relates generally to applicators and a method of coloring antiseptics. More specifically, in one embodiment, the present invention relates to an applicator having a flexible hollow body containing antiseptic to be applied. The applicator also has a porous element containing colorant positioned such that the antiseptic flows through the porous element containing colorant. Colorant is transferred to the antiseptic as it flows through the porous element. The resulting colored solution may be applied to the desired surface.

Abstract: The present invention relates generally to applicators and a method of coloring antiseptics. More specifically, in one embodiment, the present invention relates to an applicator having a flexible hollow body containing antiseptic to be applied. The applicator also has a porous element containing colorant positioned such that the antiseptic flows through the porous element containing colorant. Colorant is transferred to the antiseptic as it flows through the porous element. The resulting colored solution may be applied to the desired surface.

Abstract: A method of making a liquid applicator having a flexible hollow body within which a liquid-filled, frangible ampoule is received. The liquid applicator also has a porous element containing colorant positioned such that when the ampoule is fractured, the liquid flows through the porous element containing colorant. Colorant is transferred to the liquid as it flows through the porous element. The resulting colored solution may be applied to a desired surface.

Abstract: The present invention relates generally to liquid applicators and a method of coloring a liquid. More specifically, the present invention relates to a liquid applicator having a flexible hollow body within which a liquid-filled, glass ampoule is received. The liquid applicator also has porous element containing colorant positioned such that when the ampoule is fractured, the liquid flows through the porous element containing colorant. Colorant is transferred to the liquid as it flows through the porous element. The resulting colored solution may be applied to the desired surface.

Abstract: Applicators and a method of coloring a liquid. More specifically, the present invention relates to a liquid applicator having a flexible hollow body within which a liquid-filled, glass ampoule is received. The liquid applicator also has porous element containing colorant positioned such that when the ampoule is fractured, the liquid flows through the porous element containing colorant. Colorant is transferred to the liquid as it flows through the porous element. The resulting colored solution may be applied to the desired surface.

Abstract: The therapy with cannabinois in the treatment of cerebral tumors involves (intracranial or systematic) administration of (natural of synthetic) cannabinoids to (human or non-human) mammals having cerebral tumors. Activation of the specific receptors of the cannabinoids leads to selective death of the transformed cells. Regression or eradication of the cerebral tumors is achieved without any significant side-effects.